Skip to Main Content

Paper Details

Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19.
medRxiv
4
2022
COVID-19, CoV-2, Coronavirus, Coronavirus OC43, Fc, Fc-receptor, IgM, OC43 S2, PASC, SARS, SARS-CoV, SARS-CoV-2, acute illness, anti-SARS-CoV-2 antibodies, patient, patients, rheumatic disease
Author NameAffiliation
Nancy A ShadickBrigham and Women's Hospital
Zachary S WallaceMassachusetts General Hospital
Galit AlterRagon Institute of MGH
  • 1 - 3

Datasets